also observed proportionately larger SARS-CoV-2-specific CD4+ T cell responses than CD8+ T cell responses to different sets of overlapping peptides in the convalescent phase of both mild and severe COVID-19 cases, although in that study also IFN-ɣ+ CD8+ T cell responses were detected (8). The gene discussed is IFNA1; the disease is COVID-19.